A THAOS Sub-Study Evaluating the Effects of Tafamidis on Disease Progression in Patients with non-V30M Mutations and Symptomatic NeuropathyFirst published 30/05/2013 Last updated 14/03/2024 EU PAS number: EUPAS4027StudyFinalised